Literature DB >> 3984924

Iron stores in users of oral contraceptive agents.

E P Frassinelli-Gunderson, S Margen, J R Brown.   

Abstract

A comparison of serum ferritin and other parameters of iron status was made between 46 women taking oral contraceptive agents (OCAs) for two or more years continuously and 71 women who never took OCAs. The mean serum ferritin level for the OCA users was 39.5 +/- 21.5 ng/ml and the control group mean level was 25.4 +/- 15.96 ng/ml, which is significantly different at p less than 0.001. Serum transferrin, serum iron, TIBC, MCH and MCHC levels were significantly greater for the OCA users group. Significantly lower RBC and hematocrit levels were found for OCA users while other parameters, hemoglobin, MCV and percent transferrin saturation, were not significantly different. No major differences in subject characteristics and dietary traits were evidenced, except a difference in reported menstrual cycle losses and a higher heme iron content in the diet of the OCA users.

Entities:  

Keywords:  Anthropometry; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--side effects; Data Collection; Ethinyl Estradiol; Ethynodiol Diacetate; Examinations And Diagnoses; Family Planning; Health; Hemic System; Laboratory Examinations And Diagnoses; Laboratory Procedures; Menstrual Cycle; Menstruation; Mestranol; Norethindrone; Norethynodrel; Nutrition; Oral Contraceptives--side effects; Physiology; Population Characteristics; Reproduction; Research Methodology; Serum Iron Level--analysis

Mesh:

Substances:

Year:  1985        PMID: 3984924     DOI: 10.1093/ajcn/41.4.703

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  10 in total

1.  17β-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site.

Authors:  Qing Yang; Jinlong Jian; Stuart Katz; Steven B Abramson; Xi Huang
Journal:  Endocrinology       Date:  2012-04-25       Impact factor: 4.736

2.  Dietary and prophylactic iron supplements : Helpful or harmful?

Authors:  S Kent; E D Weinberg; P Stuart-Macadam
Journal:  Hum Nat       Date:  1990-03

3.  Oral contraceptive use, iron stores and vascular endothelial function in healthy women.

Authors:  Julie Friedman; Miriam Cremer; Qurat Ul-Ain Jelani; Xi Huang; Jinlong Jian; Sooraj Shah; Stuart D Katz
Journal:  Contraception       Date:  2011-02-24       Impact factor: 3.375

4.  Why should women have lower reference limits for haemoglobin and ferritin concentrations than men?

Authors:  D H Rushton; R Dover; A W Sainsbury; M J Norris; J J Gilkes; I D Ramsay
Journal:  BMJ       Date:  2001-06-02

5.  Albumin, oral contraceptives, and venous thromboembolism risk in astronauts.

Authors:  Sara R Zwart; Serena M Auñón-Chancellor; Martina Heer; M Mark Melin; Scott M Smith
Journal:  J Appl Physiol (1985)       Date:  2022-04-07

Review 6.  Iron considerations for the athlete: a narrative review.

Authors:  Marc Sim; Laura A Garvican-Lewis; Gregory R Cox; Andrew Govus; Alannah K A McKay; Trent Stellingwerff; Peter Peeling
Journal:  Eur J Appl Physiol       Date:  2019-05-04       Impact factor: 3.078

7.  Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment.

Authors:  N Milman; M Kirchhoff; T Jørgensen
Journal:  Ann Hematol       Date:  1992-08       Impact factor: 3.673

Review 8.  Hematological Profile Changes Among Oral Contraceptive Users: A Narrative Review.

Authors:  Esayas Tekle; Yemataw Gelaw; Fikir Asrie
Journal:  J Blood Med       Date:  2022-09-29

9.  Pediatric Reference Intervals for Transferrin Saturation in the CALIPER Cohort of Healthy Children and Adolescents.

Authors:  Victoria Higgins; Man Khun Chan; Khosrow Adeli
Journal:  EJIFCC       Date:  2017-03-08

10.  Hepcidin response to interval running exercise is not affected by oral contraceptive phase in endurance-trained women.

Authors:  Víctor M Alfaro-Magallanes; Laura Barba-Moreno; Beatriz Rael; Nuria Romero-Parra; Miguel A Rojo-Tirado; Pedro J Benito; Dorine W Swinkels; Coby M Laarakkers; Ángel E Díaz; Ana B Peinado
Journal:  Scand J Med Sci Sports       Date:  2020-12-07       Impact factor: 4.221

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.